APA

Porrata L. F., Gertz M. A., Geyer S. M., Litzow M. R., Gastineau D. A., Moore S. B., Pineda A. A., Bundy K. L., Padley D. J., Persky D., Lacy M. Q., Dispenzieri A., Snow D. S. & Markovic S. N. (20040623). The dose of infused lymphocytes in the autograft directly correlates with clinical outcome after autologous peripheral blood hematopoietic stem cell transplantation in multiple myeloma. : Leukemia.

Chicago

Porrata L F, Gertz M A, Geyer S M, Litzow M R, Gastineau D A, Moore S B, Pineda A A, Bundy K L, Padley D J, Persky D, Lacy M Q, Dispenzieri A, Snow D S and Markovic S N. 20040623. The dose of infused lymphocytes in the autograft directly correlates with clinical outcome after autologous peripheral blood hematopoietic stem cell transplantation in multiple myeloma. : Leukemia.

Harvard

Porrata L. F., Gertz M. A., Geyer S. M., Litzow M. R., Gastineau D. A., Moore S. B., Pineda A. A., Bundy K. L., Padley D. J., Persky D., Lacy M. Q., Dispenzieri A., Snow D. S. and Markovic S. N. (20040623). The dose of infused lymphocytes in the autograft directly correlates with clinical outcome after autologous peripheral blood hematopoietic stem cell transplantation in multiple myeloma. : Leukemia.

MLA

Porrata L F, Gertz M A, Geyer S M, Litzow M R, Gastineau D A, Moore S B, Pineda A A, Bundy K L, Padley D J, Persky D, Lacy M Q, Dispenzieri A, Snow D S and Markovic S N. The dose of infused lymphocytes in the autograft directly correlates with clinical outcome after autologous peripheral blood hematopoietic stem cell transplantation in multiple myeloma. : Leukemia. 20040623.